Scilex Holding Co Logo

Scilex Holding Co

Develops and commercializes non-opioid products for acute and chronic pain management.

SCLX | US

Overview

Corporate Details

ISIN(s):
US80880W2052 (+3 more)
LEI:
Country:
United States of America
Address:
960 SAN ANTONIO ROAD, 94303 PALO ALTO
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Scilex Holding Company is an innovative pharmaceutical company focused on acquiring, developing, and commercializing non-opioid products for the management of acute and chronic pain. The company's portfolio is designed to provide effective alternatives to traditional opioid medications, aiming to improve patient quality of life. Scilex utilizes proprietary technologies, including advanced adhesion and drug delivery systems like transdermal patches, precision-dosing anti-inflammatory oral solutions, and liquid ready-to-use analgesics for conditions such as migraines.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Scilex Holding Co filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Scilex Holding Co

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Scilex Holding Co via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Genmab Logo
Creates and develops antibody therapeutics for the treatment of cancer and serious diseases.
Denmark
GMAB
GENOLUTION INC. Logo
Develops molecular diagnostic and RNAi solutions for genetic testing and life sciences research.
South Korea
225220
Genome&Company Logo
Clinical-stage biopharma developing cancer therapies using microbiome, immune inhibitors, and ADCs.
South Korea
314130
Develops molecular diagnostics using DNA methylation biomarkers for early cancer detection.
South Korea
228760
Genomtec S.A. Logo
Develops a mobile platform for rapid, precise genetic diagnostics at the point-of-care.
Poland
GMT
GENOTECH CORP. Logo
A biotech firm offering gene synthesis, genome analysis, and biopharmaceutical products globally.
South Korea
066830
Genprex, Inc. Logo
A clinical-stage firm developing non-viral gene therapies for cancer and diabetes.
United States of America
GNPX
Gentian Diagnostics ASA Logo
Develops & manufactures IVD immunoassays for human & veterinary disease diagnostics.
Norway
GENT
GERON CORP Logo
Commercializes an approved, first-in-class telomerase inhibitor for blood cancers.
United States of America
GERN
GH Research PLC Logo
Clinical-stage biopharma developing mebufotenin therapies for psychiatric disorders.
United States of America
GHRS

Talk to a Data Expert

Have a question? We'll get back to you promptly.